Engineering Anti-Tumor Immunity: Strategic Design of Vaccine Constructs to Activate Durable & Potent Immune Responses
Time: 5:00 pm
day: Conference Day One
Details:
• Leveraging clinical insights from an ongoing Phase I trial to guide the design of personalized vaccine constructs
• Selecting optimal vectors, adjuvants, and delivery mechanisms to stimulate strong CD8+ T cell and memory responses
• Translating immunogenicity data into design refinements to overcome tumor immune evasion
